Related Experiment Video
Updated: Jul 14, 2026

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice
Published on: September 28, 2015
QSAR study of angiotensin II antagonists using robust boosting partial least squares regression
Yan-Ping Zhou1, Chen-Bo Cai, Shi Huan
1State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan University, Changsha 410082, China.
Abstract:
In the current study, robust boosting partial least squares (RBPLS) regression has been proposed to model the activities of a series of 4H-1,2,4-triazoles as angiotensin II antagonists. RBPLS works by sequentially employing PLS method to the robustly reweighted versions of the training compounds, and then combing these resulting predictors through weighted median. In PLS modeling, an F-statistic has been introduced to automatically determine the number of PLS components. The results obtained by RBPLS have been compared to those by boosting partial least squares (BPLS) repression and partial least squares (PLS) regression, showing the good performance of RBPLS in improving the QSAR modeling. In addition, the interaction of angiotensin II antagonists is a complex one, including topological, spatial, thermodynamic and electronic effects.
Related Concept Videos
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Antihypertensive Drugs: Direct Renin Inhibitors
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...